KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $5.1 million.

  • Globus Medical's Asset Writedowns and Impairment rose 725.65% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.2 million, marking a year-over-year increase of 1320.1%. This contributed to the annual value of $23.4 million for FY2024, which is 11314.9% up from last year.
  • Latest data reveals that Globus Medical reported Asset Writedowns and Impairment of $5.1 million as of Q3 2025, which was up 725.65% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Asset Writedowns and Impairment ranged from a high of $7.6 million in Q2 2024 and a low of $510000.0 during Q4 2022
  • For the 5-year period, Globus Medical's Asset Writedowns and Impairment averaged around $3.3 million, with its median value being $2.7 million (2023).
  • As far as peak fluctuations go, Globus Medical's Asset Writedowns and Impairment plummeted by 8924.95% in 2021, and later skyrocketed by 73509.8% in 2023.
  • Quarter analysis of 5 years shows Globus Medical's Asset Writedowns and Impairment stood at $573000.0 in 2021, then dropped by 10.99% to $510000.0 in 2022, then soared by 735.1% to $4.3 million in 2023, then surged by 68.23% to $7.2 million in 2024, then dropped by 29.45% to $5.1 million in 2025.
  • Its last three reported values are $5.1 million in Q3 2025, $5.0 million for Q2 2025, and $6.0 million during Q1 2025.